| index | Title |
| 1 | Increased fatty acid synthase as a potential therapeutic target in multiple myeloma Author(s):Wei-qin WANG, Xiao-ying ZHAO, Hai-... Clicked:10862 Download:7158 Cited:22 <Full Text> Journal of Zhejiang University Science B 2008 Vol.9 No.6 P.441-447 DOI:10.1631/jzus.B0740640 |
| 2 | IgE myeloma with elevated level of serum CA125 Author(s):Man-ling WANG, Qiang HUANG, Tian-x... Clicked:8878 Download:4284 Cited:9 <Full Text> Journal of Zhejiang University Science B 2009 Vol.10 No.7 P.559-562 DOI:10.1631/jzus.B0820399 |
| 3 | Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma Author(s):He Huang, Heng-Wei Wu, Yong-Xian Hu Clicked:7545 Download:4469 Cited:0 <Full Text> <PPT> 2856 Journal of Zhejiang University Science B 2020 Vol.21 No.1 P.29-41 DOI:10.1631/jzus.B1900351 |
| 4 | Circular RNAs: typical biomarkers for bone-related diseases Author(s):Linghui HU, Wei WU, Jun ZOU Clicked:3448 Download:3161 Cited:0 <Full Text> <PPT> 1494 Journal of Zhejiang University Science B 2022 Vol.23 No.12 P.975-988 DOI:10.1631/jzus.B2200211 |
| 5 | High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in ... Author(s):Xiaoyan YUE, Linlin HUANG, Yang YA... Clicked:3895 Download:3569 Cited:0 <Full Text> <PPT> 1848 Journal of Zhejiang University Science B 2022 Vol.23 No.11 P.968-974 DOI:10.1631/jzus.B2200277 |
| 6 | CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by reg... Author(s):Wen CAO, Shunnan YAO, Anqi LI, Hao... Clicked:4363 Download:3049 Cited:0 <Full Text> <PPT> 1380 Journal of Zhejiang University Science B 2023 Vol.24 No.5 P.442-454 DOI:10.1631/jzus.B2200465 |
| 7 | Relapse mechanisms and disease management strategies after BCMA CAR-T therapy for multiple myeloma Author(s):Jiahao HE1,2,Clicked:279 Download:274 Cited:0 <Full Text> Journal of Zhejiang University Science B 1998 Vol.-1 No.-1 P. DOI:10.1631/jzus.B2500466 |